Personal tragedy led Doug Evans, founder of Exton-based Kensey Nash, to change his business trajectory and become CEO of ...

Casualty has been pulled from the BBC One schedule on Saturday night as the channel's usual line-up is replaced ...

Cancer treatment has long faced a challenging trade-off: therapies strong enough to eliminate tumors often cause severe side effects. One promising solution involves cytokines, natural proteins that ...

Can research into a rare, accelerated aging disease and "zombie cells" teach us something about the normal aging process?

As Kate, the Princess of Wales, returns to work at her own pace, she made a personal visit to Colchester Hospital where she spoke with cancer patients and staff about the roller coaster of diagnosis, ...

Farnesoid X receptor (FXR) has become a particularly attractive target for the discovery of drugs for the treatment of liver and metabolic diseases. Obeticholic acid (INT-747), a FXR agonist, has ...

Recently, there has been a significant development on the horizon in the field of liver disease research. Scientists have identified a potential new treatment that holds the potential to transform the ...